| 注册
首页|期刊导航|神经药理学报|成人注意力缺陷/多动障碍的流行病学研究和药物治疗进展

成人注意力缺陷/多动障碍的流行病学研究和药物治疗进展

刘治军

神经药理学报Issue(5):31-39,9.
神经药理学报Issue(5):31-39,9.

成人注意力缺陷/多动障碍的流行病学研究和药物治疗进展

Epidemiology and Pharmacotherapy of Adult Attention Deifcit/Hyperactivity Disorder:Current Status

刘治军1

作者信息

  • 1. 卫生部北京医院药学部,北京,100730,中国
  • 折叠

摘要

Abstract

Attention deficit/hyperactivity disorder(ADHD)is the most frequently diagnosed neuro-developmental disorder in children and most of the children ADHD cases can persist to adulthood. The DSM-5 developed and published by American Psychiatric Association(APA)at 2012 firstly gives the more appropriate diagnosis criteria and regulates pharmacotherapies for adult ADHD. The currently used medications include neural stimulants(e.g. methylphenidate and amphetamines)and non-stimulants(e.g. atomoxetine,buproprion and tricyclic antidepressants). Other medications such as venlafaxine,reboxetine,modafinil,oxcarbazepine and propranolol are also tried to treat adult ADHD and showed a certain effects.

关键词

注意力缺陷/多动障碍/诊断/治疗

Key words

attention deficit/hyperactivity disorder/diagnosis/treatment

分类

医药卫生

引用本文复制引用

刘治军..成人注意力缺陷/多动障碍的流行病学研究和药物治疗进展[J].神经药理学报,2012,(5):31-39,9.

神经药理学报

2095-1396

访问量0
|
下载量0
段落导航相关论文